As of 2025-02-09, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 19.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.55 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 5.8%.
The range of the Relative Valuation is 15.40 - 25.35 USD.
Range | Selected | |
Trailing P/E multiples | 19.9x - 25.3x | 22.2x |
Forward P/E multiples | 24.6x - 32.8x | 28.6x |
Fair Price | 15.40 - 25.35 | 19.62 |
Upside | -17.0% - 36.6% | 5.8% |
Date | P/E |
2025-02-07 | 24.02 |
2025-02-06 | 24.77 |
2025-02-05 | 25.38 |
2025-02-04 | 24.25 |
2025-02-03 | 23.97 |
2025-01-31 | 24.16 |
2025-01-30 | 24.20 |
2025-01-29 | 23.79 |
2025-01-28 | 23.82 |
2025-01-27 | 23.66 |
2025-01-24 | 24.17 |
2025-01-23 | 24.70 |
2025-01-22 | 23.06 |
2025-01-21 | 23.16 |
2025-01-17 | 22.75 |
2025-01-16 | 22.68 |
2025-01-15 | 22.67 |
2025-01-14 | 21.88 |
2025-01-13 | 23.18 |
2025-01-10 | 22.35 |
2025-01-08 | 22.79 |
2025-01-07 | 22.52 |
2025-01-06 | 22.61 |
2025-01-03 | 23.84 |
2025-01-02 | 24.16 |
2024-12-31 | 23.76 |
2024-12-30 | 21.61 |
2024-12-27 | 21.95 |
2024-12-26 | 22.49 |
2024-12-24 | 22.10 |
2024-12-23 | 22.23 |
2024-12-20 | 21.84 |
2024-12-19 | 21.66 |
2024-12-18 | 21.90 |
2024-12-17 | 22.54 |
2024-12-16 | 22.45 |
2024-12-13 | 22.35 |
2024-12-12 | 22.35 |
2024-12-11 | 23.33 |
2024-12-10 | 23.99 |
2024-12-09 | 24.29 |
2024-12-06 | 22.37 |
2024-12-05 | 21.64 |
2024-12-04 | 22.23 |
2024-12-03 | 21.11 |
2024-12-02 | 21.51 |
2024-11-29 | 21.13 |
2024-11-27 | 21.09 |
2024-11-26 | 20.99 |
2024-11-25 | 21.42 |